Evidence map›Paper›PMID 35191835›Full record

ArticleeLife2022

TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microglia.

Amit Jairaman, Amanda McQuade, Alberto Granzotto, You Jung Kang, Jean Paul Chadarevian, Sunil Gandhi, Ian Parker, Ian Smith, Hansang Cho, Stefano L Sensi and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Roles of TREM2 in Alzheimer's disease.Translational neurodegeneration · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Microglia, Trem2, and Neurodegeneration.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2025
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Amit Jairaman *Department of Physiology and Biophysics, University of California, Irvine, Irvine, United States.ORCID 0000-0002-5206-700X
Amanda McQuade *Department of Neurobiology and Behavior, University of California, Irvine, Irvine, United States.ORCID 0000-0001-5368-6788
Alberto GranzottoDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, United States.
You Jung KangDepartment of Mechanical Engineering and Engineering Science, University of North Carolina, Charlotte, United States.
Jean Paul ChadarevianDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, United States.
Sunil GandhiDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, United States.
Ian ParkerDepartment of Physiology and Biophysics, University of California, Irvine, Irvine, United States.
Ian SmithDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, United States.ORCID 0000-0001-9910-195X
Hansang ChoInstitute of Quantum Biophysics, Department of Biophysics, Dept of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Gyeonggi-do, Republic of Korea.
Stefano L SensiCenter for Advanced Sciences and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.
Shivashankar OthyDepartment of Physiology and Biophysics, University of California, Irvine, Irvine, United States.ORCID 0000-0001-6832-5547
Mathew Blurton-JonesDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, United States.ORCID 0000-0002-7770-7157
Michael D CahalanDepartment of Physiology and Biophysics, University of California, Irvine, Irvine, United States.ORCID 0000-0002-4987-2526
University of California, Irvine · USSungkyunkwan University · KRUniversity of California, San Francisco · USUniversity of Chieti-Pescara · IT

Funding

The Alzheimer's Disease Research Center at the University of California, IrvineP30AG066519 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Elizabeth Head · 2020 to 2026
$27.9M
Molecular Mechanisms of lon Channels in T LymphocytesR01NS014609 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI CAHALAN, MICHAEL D · 1985 to 2022
$7.0M
Training Program in Stem Cell Translational Medicine for Neurological DisordersT32NS082174 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI PETER John DONOVAN, Leslie Michels Thompson · 2013 to 2026
$3.3M
Examining the role of adaptive immunity in Alzheimer's Disease pathogenesisRF1AG055524 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLURTON-JONES, MATHEW MARK · 2017 to 2017
$2.7M
Cellular and Molecular Mechanisms of Regulatory T Cells in EAER01AI121945 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CAHALAN, MICHAEL D · 2016 to 2020
$2.5M
Defining molecular mechanisms of combination adjuvants: a systems immunology, transcriptomics and imaging approachU01AI160397 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI DAVIES, DAVID HUW · 2021 to 2024
$2.4M
A novel platform for the investigation of human microgliaRF1DA048813 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLURTON-JONES, MATHEW MARK, GANDHI, SUNIL · 2019 to 2021
$2.1M
Manipulating DNA repair enzymes to examine the interactions between aging and Alzheimers disease with iPSC-derived microgliaR01AG056303 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLURTON-JONES, MATHEW MARK · 2017 to 2021
$1.9M
The role of TREM2 in human microglial function and Alzheimer disease pathogenesisRF1AG048099 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLURTON-JONES, MATHEW MARK · 2014 to 2014
$1.9M
To prove the interplaying roles of central and peripheral immunity in Alzheimer's diseaseR15AG059236 · NIA · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI LEE, CHARLES · 2019 to 2019
$426k
Cellular and Molecular Mechanisms of Regulatory T Cells in EAER56AI121945 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CAHALAN, MICHAEL D · 2016 to 2016
$103k
NIAID NIH HHS R01 AI121945NIAID NIH HHS R56 AI121945NIAID NIH HHS U01 AI160397NIA NIH HHS P30 AG066519NIA NIH HHS R01 AG056303NIA NIH HHS R15 AG059236NIA NIH HHS RF1 AG048099NIA NIH HHS RF1 AG055524NIDA NIH HHS RF1 DA048813NINDS NIH HHS R01 NS014609NINDS NIH HHS T32 NS082174
6 · The paper itself

Abstract

The membrane protein TREM2 (Triggering Receptor Expressed on Myeloid cells 2) regulates key microglial functions including phagocytosis and chemotaxis. Loss-of-function variants of TREM2 are associated with increased risk of Alzheimer's disease (AD). Because abnormalities in Ca

Indexed as

Alzheimer DiseaseInduced Pluripotent Stem CellsAdenosine DiphosphateCalciumCalcium SignalingHumansMembrane GlycoproteinsMicrogliaReceptors, ImmunologicReceptors, PurinergicAdenosine DiphosphateCalciumMembrane GlycoproteinsReceptors, ImmunologicReceptors, PurinergicTREM2 protein, humanAlzheimer's diseaseCa2+ signalinghumanimmunologyinflammationiPSC-derived microglianeuroscienceP2Y receptorstore-operated Ca2+ entryTREM2

Identifiers

PMID35191835
PMCPMC8906810
OpenAlexW4221108952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.